If you're researching pattern hair loss treatment, finasteride is one of two medications you'll see again and again. Alongside minoxidil, it's the foundation of evidence-based medical treatment for androgenetic alopecia in men, with more than two decades of clinical data supporting it. But finasteride works in a fundamentally different way from minoxidil, and understanding that difference matters when you're deciding what's right for you.
Here's a clear, evidence-based look at how finasteride treats hair loss, what the research actually shows, and what to weigh before starting it.
A prostate drug that protects hair
Like minoxidil, finasteride's role in hair loss treatment came from an unexpected place. It was first developed in the 1980s to treat benign prostatic hyperplasia, an enlargement of the prostate gland that affects many older men. At a 5 mg daily dose, it shrinks prostate tissue. Researchers noticed that men taking it were also keeping more of their hair.
A second wave of trials at a much lower dose (1 mg per day) followed, and in 1997 the FDA approved finasteride 1 mg for the treatment of male pattern hair loss. Today it remains one of only two medications with a specific FDA indication for hair loss, the other being minoxidil.
How it actually works
Pattern hair loss in men is driven primarily by a hormone called dihydrotestosterone, or DHT. DHT is a more potent metabolite of testosterone, and in genetically susceptible follicles (typically the crown, frontal scalp, and temples), it binds to receptors and triggers a process called miniaturization. Over years and decades, follicles shrink, producing progressively shorter, finer, less pigmented hairs until they stop producing visible hair at all.
Finasteride works upstream of that process. It's a 5-alpha-reductase inhibitor, which means it blocks the enzyme responsible for converting testosterone into DHT. At the standard 1 mg daily dose, finasteride lowers scalp DHT by roughly 60 to 70%, which is enough to halt or reverse miniaturization in most patients (Drake et al., J Am Acad Dermatol, 1999).
A few things to note about that mechanism:
- It addresses the root cause, not the symptom. Where minoxidil prolongs the growth phase and improves follicle output, finasteride goes after the hormonal driver of hair loss itself.
- It's specific to type II 5-alpha-reductase. This is the form of the enzyme most active in scalp follicles. Dutasteride, a related drug, blocks both type I and type II, which is why it lowers DHT more aggressively.
- It does not lower testosterone. Total testosterone usually stays in the normal range or even rises slightly, since less of it is being converted to DHT.
What the evidence shows
Finasteride has one of the strongest evidence bases of any hair loss medication. Headline findings from the clinical literature:
- About 80 to 90% of men stop losing hair. In the pivotal 5-year trial of finasteride 1 mg in men with androgenetic alopecia, roughly 90% of treated men either maintained or improved their hair count, compared with about 25% on placebo (Kaufman et al., J Am Acad Dermatol, 1998).
- Around two-thirds see visible regrowth. Roughly 65% of men show measurable regrowth at 2 years, with the strongest response in the crown and a more modest but real response in the frontal scalp.
- Combination therapy outperforms either drug alone. Multiple studies have found that finasteride plus minoxidil produces better hair count and density outcomes than either medication on its own. For more on how they pair, see our companion guide on how minoxidil treats hair loss.
- Like minoxidil, it requires ongoing use. When finasteride is stopped, scalp DHT rebounds within weeks, and the underlying pattern of hair loss resumes. Most of the hair gained during treatment is lost within 12 months of discontinuation.
Side effects and what to actually weigh
Finasteride is generally well tolerated, but the side effect conversation is the part that deserves the most care. The categories most often discussed:
- Sexual side effects. A small percentage of men report decreased libido, erectile difficulty, or reduced ejaculate volume. In the original FDA trials, the rate of any sexual side effect was about 3.8% on finasteride versus 2.1% on placebo, a real but modest difference. In most men who experience them, the effects resolve either while continuing the medication or after discontinuation (Mella et al., Arch Dermatol, 2010).
- Mood changes. Some patients report low mood or reduced motivation. The data on causality is mixed, and good prospective studies are limited, but it's a recognized possibility worth raising with your physician if you notice it.
- Post-finasteride syndrome. A small subset of users have reported persistent symptoms after stopping finasteride. The condition is not yet fully characterized in the medical literature, and rates appear to be low, but the concern is real enough that any prescribing physician should discuss it with you up front.
- Breast tenderness or enlargement. Uncommon but documented.
- Pregnancy precautions. Finasteride should not be handled by pregnant women because of risks to a developing male fetus. This is mostly relevant for crushed or broken tablets.
The honest framing: most men tolerate finasteride well, and the evidence for its efficacy is strong. But the decision to take it is genuinely a clinical one, and a physician should walk you through your individual risk profile, your goals, and what to monitor for after you start.
Oral, topical, and dose variations
The standard of care is oral finasteride 1 mg per day. A few variations are worth knowing about:
- Topical finasteride is a newer option that delivers the medication directly to the scalp, with the goal of reducing systemic exposure. Early evidence is promising, but the formulation and dose still vary widely, and long-term data is more limited than for the oral version.
- Lower-dose regimens (for example, 0.5 mg daily or 1 mg every other day) are sometimes used to reduce side effect risk while preserving most of the benefit. This is a clinical decision, not a self-adjustment.
- Dutasteride is a related but more potent 5-alpha-reductase inhibitor used in some patients who don't respond fully to finasteride. It's prescribed off-label for hair loss in the United States.
If you're weighing finasteride against other options, our overview of what to expect in the first 6 months of hair loss treatment covers the realistic timeline regardless of which medication you start on.
The bottom line
Finasteride works, and the evidence for it is among the most robust in hair loss medicine. It addresses the hormonal driver of pattern hair loss directly, and for most men who take it consistently, it slows or stops the progression of androgenetic alopecia, often with visible regrowth. Side effects are uncommon but not zero, and a physician's review is the appropriate place to weigh them against the benefit.
If you're considering finasteride, the right next step is a conversation with a licensed clinician who can review your history, discuss the side effect profile in detail, and decide whether oral treatment on its own, in combination with topical treatment, or another approach entirely makes sense for you.
Hair loss is treatable. The medications that work, work because the science behind them is well understood. Make your decision from that foundation.
